Long-term outcomes of patients with soft tissue sarcoma of the chest wall: Analysis of the prognostic significance of microscopic margins

Data on prognostic factors and treatment outcomes for chest wall soft tissue sarcomas (STS) are sparse. Wide resections with negative margins are the mainstay of therapy, but the prognostic impact of surgical margins remains controversial. The purpose of the present study was to determine the significance of microscopic margins through a long-term follow-up. The associations between local recurrence-free survival (LRFS), overall survival (OS) and potential prognostic factors were retrospectively assessed in a consecutive series of 110 patients who were suitable for surgical treatment with curative intent. Potential prognostic factors were assessed using univariate and multivariate analyses. The median follow-up time following primary diagnosis was 9.6 years [95% confidence interval (CI), 7.2–10.5]. In the entire cohort, the 5-year estimates of the OS and LRFS rates were 66.0% (95% CI, 55.9–74.3) and 60.6% (95% CI, 50.3–69.4), respectively. A total of 27 patients (24.5%) developed distant metastases with a median survival time of 0.9 years following the diagnosis of metastasis. Surgical margins attained at the initial resection and eventual re-excisions significantly influenced OS in univariate analysis (5-year OS, R0 69.9% vs. R1/R2 38.5%; P=0.046), but this failed to reach statistical significance in the multivariate analysis. In the multivariate analysis, significant adverse prognostic features of LRFS included angiosarcoma subtype, G2 and G3 histology. For OS, the only independent significant predictors were age >50 years, tumor size >5 cm, angiosarcoma subtype and G3 histology. The results of the present study suggest that tumor biology, as reflected by the histological grade, influences the final outcome in patients with chest wall STS. Surgical margins failed to reach statistical significance in multivariate analysis as they demonstrated a dependency towards the independent predictors of OS. Subsequently, a positive margin status may be a result rather than a cause of biological aggressiveness, and it may not influence the outcome directly.

[1]  D. Oksuz,et al.  Long-term treatment results in soft tissue sarcomas of the thoracic wall treated with pre-or-postoperative radiotherapy--a single institution experience. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[2]  U. Pastorino,et al.  Primary chest wall chondrosarcomas: results of surgical resection and analysis of prognostic factors. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[3]  P. Jørgensen,et al.  Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall , 2014, Acta orthopaedica.

[4]  C. Fletcher The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification , 2014, Histopathology.

[5]  C. Sima,et al.  Recurrence patterns after resection of soft tissue sarcomas of the chest wall. , 2013, The Annals of thoracic surgery.

[6]  R. Cameron,et al.  Single-Institution, Multidisciplinary Experience with Surgical Resection of Primary Chest Wall Sarcomas , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  R. Grimer,et al.  Trends in presentation of bone and soft tissue sarcomas over 25 years: little evidence of earlier diagnosis. , 2011, Annals of the Royal College of Surgeons of England.

[8]  A. V. van Geel,et al.  Chest Wall Resection for Adult Soft Tissue Sarcomas and Chondrosarcomas: Analysis of Prognostic Factors , 2010, World Journal of Surgery.

[9]  M. Bertagnolli,et al.  Secondary sarcomas after radiotherapy for breast cancer , 2009, Cancer.

[10]  N. Ishiguro,et al.  Soft Tissue Sarcomas of the Chest Wall , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  F. Collin,et al.  Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  H. Bauer,et al.  Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: a population-based Scandinavian Sarcoma Group study of 106 patients. , 2009, The Journal of thoracic and cardiovascular surgery.

[13]  F. van Coevorden,et al.  Outcome after surgical resections of recurrent chest wall sarcomas. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Coindre Grading of soft tissue sarcomas: review and update. , 2009, Archives of pathology & laboratory medicine.

[15]  C. Pinto,et al.  Soft-tissue sarcomas of the chest wall: prognostic factors. , 2005, Chest.

[16]  T G Clark,et al.  Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.

[17]  Axel Hoos,et al.  Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.

[18]  F. Collin,et al.  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas , 2001, Cancer.

[19]  J. Roth,et al.  A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. , 2001, The Journal of thoracic and cardiovascular surgery.

[20]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[21]  M. Bains,et al.  Soft tissue sarcomas of the chest wall. Results of surgical resection. , 1991, The Journal of thoracic and cardiovascular surgery.

[22]  B Sundell,et al.  Soft-tissue sarcomas. , 1979, British medical journal.